Clarissa Campbell

Clarissa Campbell

Auto-generated profile, based on publicly available information

Clarissa Campbell

CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria ; Division of Microbial Ecology, Department of Microbiology and Ecosystem Science, Center for Microbiology and Environmental Systems Science, University of V

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2013 in Nature
Verified
Journal Article
Open access
PDF file
NANicholas Arpaia
Nicholas Arpaia
CCClarissa Campbell
Clarissa Campbell
XFXiying Fan
Xiying Fan
SDStanislav Dikiy
Stanislav Dikiy
JVJoris van der Veeken
Joris van der Veeken
ARAlexander Y. Rudensky
Alexander Y. Rudensky
In mice, provision of butyrate—a short-chain fatty acid produced by commensal microorganisms during starch fermentation—facilitates extrathymic generation and differentiation of Foxp3+ regulatory T cells, demonstrating that metabolic by-products are sensed by cells of the immune system and affect the balance between pro- and anti-inflammatory cells. Several lines of evidence indicate that subsets of commensal microbes shape the gut immune system. For instance, colonization with Clostridia promotes extrathymic generation of regulatory T (Treg) cells that have a central role in the suppression of inflammatory and allergic responses. However, the molecular basis of such microbe-mediated Treg induction remains unknown. Two papers in this issue of Nature show that the colonic microbial fermentation product butyrate significantly accelerates the differentiation of colonic Treg cells and ameliorates colitis in conjunction with an increase in histone H3 acetylation at the Foxp3 promoter. This finding links butyrate to the induction of functional Treg cells in the colonic mucosa, and also provides molecular insight into the therapeutic application of butyrate. Intestinal microbes provide multicellular hosts with nutrients and confer resistance to infection. The delicate balance between pro- and anti-inflammatory mechanisms, essential for gut immune homeostasis, is affected by the composition of the commensal microbial community. Regulatory T cells (Treg cells) expressing transcription factor Foxp3 have a key role in limiting inflammatory responses in the intestine1. Although specific members of the commensal microbial community have been found to potentiate the generation of anti-inflammatory Treg or pro-inflammatory T helper 17 (TH17) cells2,3,4,5,6, the molecular cues driving this process remain elusive. Considering the vital metabolic function afforded by commensal microorganisms, we reasoned that their metabolic by-products are sensed by cells of the immune system and affect the balance between pro- and anti-inflammatory cells. We tested this hypothesis by exploring the effect of microbial metabolites on the generation of anti-inflammatory Treg cells. We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by commensal microorganisms during starch fermentation, facilitated extrathymic generation of Treg cells. A boost in Treg-cell numbers after provision of butyrate was due to potentiation of extrathymic differentiation of Treg cells, as the observed phenomenon was dependent on intronic enhancer CNS1 (conserved non-coding sequence 1), essential for extrathymic but dispensable for thymic Treg-cell differentiation1,7. In addition to butyrate, de novo Treg-cell generation in the periphery was potentiated by propionate, another SCFA of microbial origin capable of histone deacetylase (HDAC) inhibition, but not acetate, which lacks this HDAC-inhibitory activity. Our results suggest that bacterial metabolites mediate communication between the commensal microbiota and the immune system, affecting the balance between pro- and anti-inflammatory mechanisms.

15 April 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CCClarissa Campbell
Clarissa Campbell
PMPeter T. McKenney
Peter T. McKenney
DKDaniel Konstantinovsky
Daniel Konstantinovsky
OIOlga I. Isaeva
Olga I. Isaeva
MSMichail Schizas
Michail Schizas
ARAlexander Y. Rudensky
Alexander Y. Rudensky

30 April 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RJRobert R. Jenq
Robert R. Jenq
CÚCarles Úbeda
Carles Úbeda
YTYing Taur
Ying Taur
CMClarissa C. Menezes
Clarissa C. Menezes
RKRaya Khanin
Raya Khanin
MBMarcel R.M. van Den Brink
Marcel R.M. van Den Brink
Despite a growing understanding of the link between intestinal inflammation and resident gut microbes, longitudinal studies of human flora before initial onset of intestinal inflammation have not been reported. Here, we demonstrate in murine and human recipients of allogeneic bone marrow transplantation (BMT) that intestinal inflammation secondary to graft-versus-host disease (GVHD) is associated with major shifts in the composition of the intestinal microbiota. The microbiota, in turn, can modulate the severity of intestinal inflammation. In mouse models of GVHD, we observed loss of overall diversity and expansion of Lactobacillales and loss of Clostridiales. Eliminating Lactobacillales from the flora of mice before BMT aggravated GVHD, whereas reintroducing the predominant species of Lactobacillus mediated significant protection against GVHD. We then characterized gut flora of patients during onset of intestinal inflammation caused by GVHD and found patterns mirroring those in mice. We also identified increased microbial chaos early after allogeneic BMT as a potential risk factor for subsequent GVHD. Together, these data demonstrate regulation of flora by intestinal inflammation and suggest that flora manipulation may reduce intestinal inflammation and improve outcomes for allogeneic BMT recipients.

28 September 2024 in Journal of Hepatology
Verified
Journal Article
Open access
CFClaudia D. Fuchs
Claudia D. Fuchs
BSBenedikt Simbrunner
Benedikt Simbrunner
MBMaximillian Baumgartner
Maximillian Baumgartner
CCClarissa Campbell
Clarissa Campbell
TRThomas Reiberger
Thomas Reiberger
MTMichael Trauner
Michael Trauner
Bile acids (BAs) serve as signalling molecules, efficiently regulating their own metabolism and transport, as well as key aspects of lipid and glucose homeostasis. BAs shape the gut microbial flora and conversely are metabolised by microbiota. Disruption of BA transport, metabolism and physiological signalling functions contribute to the pathogenesis and progression of a wide range of liver diseases including cholestatic disorders and MASLD (metabolic dysfunction-associated steatotic liver disease), as well as hepatocellular and cholangiocellular carcinoma. Additionally, impaired BA signalling may also affect the intestine and kidney, thereby contributing to failure of gut integrity and driving the progression and complications of portal hypertension, cholemic nephropathy and the development of extrahepatic malignancies such as colorectal cancer. In this review, we will summarise recent advances in the understanding of BA signalling, metabolism and transport, focusing on transcriptional regulation and novel BA-focused therapeutic strategies for cholestatic and metabolic liver diseases.

10 October 2019 in Cell Metabolism
Verified
Journal Article
Closed access
CCClarissa Campbell
Clarissa Campbell
ARAlexander Rudensky
Alexander Rudensky

1 June 2018 in Immunity
Verified
Journal Article
Closed access
CCClarissa Campbell
Clarissa Campbell
SDStanislav Dikiy
Stanislav Dikiy
SBShakti K. Bhattarai
Shakti K. Bhattarai
TCTakatoshi Chinen
Takatoshi Chinen
FMFanny Matheis
Fanny Matheis
ARAlexander Y. Rudensky
Alexander Y. Rudensky